Furthermore, one cannot exclude the fact that the twelve‐week timeline followed in this study to assess the molecular changes underlying the progression of DCM lies most probably within the pathophysiological window that precedes any alterations occurring in Epac2 protein levels. Here, RAPGEF4 is linked to familial dilated cardiomyopathy.